Population pharmacokinetics and pharmacodynamics of oral levodopa in parkinsonian patients

European Journal of Clinical Pharmacology

Volumn 51, Issue 1, 1996, Pages 59-67

  Triggs, E J ^a   Charles, B G ^a   Contin, M ^b   Martinelli, P ^b   Cortelli, P ^b   Riva, R ^b   Albani, F ^b   Baruzzi, A ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Levodopa; NONMEM; Parkinson's disease; Pharmacodynamics; Pharmacokinetics

Indexed keywords

BENSERAZIDE; BENSERAZIDE PLUS LEVODOPA; CARBIDOPA; LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PHARMACODYNAMICS; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; AGED; ANIMALS; ANTIPARKINSON AGENTS; BAYES THEOREM; CATS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PARKINSON DISEASE;

EID: 0029764853     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050161     Document Type: Article

References (18)

1. Aarons L, Mandema JW, Danhof M (1991) A population analysis of the pharmacokinetics and pharmacodynamics of midazolam in the rat. J Pharmacokin Biopharm 19:485-496
2. Baruzzi A, Contin M, Albani F, Riva R (1986) Simple and rapid micromethod for the determination of levodopa and 3-O-methyldopa in human plasma by high-performance liquid chromatography with coulometric detection. J Chromatogr 375: 165-169
3. Boeckmann AJ, Beal SL, Sheiner LB (1992) NONMEM User Guides, NONMEM Project Group, University of California, San Francisco, CA, USA
4. Bredberg E, Tedroff J, Aquilonius SM, Paalzow L (1990) Pharmacokinetics and effects of levodopa in advanced Parkinson's disease. Eur J Clin Pharmacol 39:385-389
5. Contin M, Riva R, Martinelli P, Procaccianti G, Cortelli P, Avoni P, Baruzzi A (1990) Response to a standard oral levodopa test in parkinsonian patients with and without motor fluctuations. Clin Neuropharmacol 13:19-28
6. Contin M, Riva R, Martinelli P, Cortelli P, Albani F, Baruzzi A (1993) Pharmacodynamic modelling of oral levodopa: Clinical application in Parkinson's disease. Neurology 43:367-371
7. Contin M, Riva R, Martinelli P, Cortelli P, Albani F, Baruzzi A (1994) Longitudinal monitoring of the levodopa concentration-effect relationship in Parkinson's disease. Neurology 44: 1287-1292
8. Elkoshi Z (1994) Concentration-effect relationship following levodopa/carbidopa administration to "on-off" parkinsonian patients. Clin Neuropharmacol 17:147-164
9. Fabbrini G, Juncos JL, Mouradian MM, Chase TN (1987) Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease. Ann Neurol 21:370-376
10. Gancher ST, Nutt JG, Woodward WR (1987) Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating parkinsonian patients. Neurology 37:940-944
11. Harder S, Baas H, Bergemann N, Demisch L, Rietbrock S (1995) Concentration-effect relationship of levodopa in patients with Parkinson's disease after oral administration of an immediate release and a controlled release formulation. Br J Clin Pharmacol 39:39-44
12. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427-442
13. Mandema JW, Verotta D, Sheiner LB (1992) Building population pharmacokinetic-pharmacodynamic models I. Models for covariate effects. J Pharmacokin Biopharm 20:511-528
14. Marsden CD (1994) Parkinson's disease. J Neurol Neurosurg 57: 672-681
15. Nelson MV, Berchou RC, Lewitt PA, Kareti D, Galloway MP (1989) Pharmacodynamic modelling of concentration-effect relationships after controlled-release carbidopa/levodopa (Sinemet CR4) in Parkinson's disease. Neurology 40:70-74
16. Sheiner LB, Beal SL (1981) Some suggestions for measuring predictive performance. J Pharmacokin Biopharm 4:503-512
17. Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J (1979) Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to D-tubocurarine. Clin Pharmacol Ther 25:358-371
18. Weber W, Kewitz G, Rost KL, Looby M, Nitz M, Harnisch L (1993) Population kinetics of gentamicin in neonates. Eur J Clin Pharmacol 44 [Suppl 1]: S23-S25